Fox River Resources Stock (OTC:FXRVF), Trade Ideas

Fox River Resources Corp is engaged in the advancement of the Martison Phosphate Project located near Hearst, Ontario. The project entails the construction of a vertically integrated phosphoric acid facility. The plant would utilize the Martison phosphate deposit and sulphuric acid from existing nearby base metal smelters or a sulphuric acid plant built by the company utilizing low-cost sulphur from Western Canada. The acidulation of these two primary inputs would be utilized to create phosphoric acid used to produce products in the fertilizer and industrial phosphate markets.

Fox River Resources Corp

International Paper (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IP#NYSE">IP</a>) reported quarterly earnings of $0.17 per share which missed the analyst consensus estimate of $0.22 by 22.73 percent. This is a 67.92 percent decrease over earnings of $0.53 per share from the same period last year. The company reported quarterly sales of $4.62 billion which beat the analyst consensus estimate of $4.56 billion by 1.29 percent. This is a 7.99 percent decrease over sales of $5.02 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

News

International Paper Q1 Adj $0.17 Misses $0.22 Estimate, Sales $4.62B Beat $4.56B Estimate

Southwest Airlines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.34) by 5.88 percent. The company reported quarterly sales of $6.33 billion which missed the analyst consensus estimate of $6.42 billion by 1.42 percent. This is a 10.92 percent increase over sales of $5.71 billion the same period last year.

Southwest Airlines Q1 2024 Adj EPS $(0.36) Misses $(0.34) Estimate, Sales $6.33B Miss $6.42B Estimate

MarineMax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HZO#NYSE">HZO</a>) reported quarterly earnings of $0.18 per share which missed the analyst consensus estimate of $0.66 by 72.73 percent. The company reported quarterly sales of $582.900 million which missed the analyst consensus estimate of $590.189 million by 1.23 percent. This is a 2.20 percent increase over sales of $570.340 million the same period last year.

MarineMax Q2 2024 Adj EPS $0.18 Misses $0.66 Estimate, Sales $582.900M Miss $590.189M Estimate

Baird analyst Luke Junk maintains Amphenol (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>) with a Outperform and raises the price target from $123 to $124.

Price Target

Analyst Ratings

Baird Maintains Outperform on Amphenol, Raises Price Target to $124

Needham analyst Scott Berg reiterates Paycor HCM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYCR#NASDAQ">PYCR</a>) with a Buy and maintains $42 price target.

Reiteration

PYCR

Needham Reiterates Buy on Paycor HCM, Maintains $42 Price Target

Updated Fiscal 2024&nbsp;Guidance
For fiscal 2024, the Company now projects EPS of&nbsp;$9.55&nbsp;to&nbsp;$9.70&nbsp;on an adjusted basis (prior&nbsp;$9.35&nbsp;to&nbsp;$9.70), sales growth of&nbsp;1.5%&nbsp;to&nbsp;2.5%&nbsp;(prior&nbsp;1%&nbsp;to&nbsp;3%) including&nbsp;0.5%&nbsp;to&nbsp;1.5%&nbsp;on an organic daily basis (prior&nbsp;0%&nbsp;to&nbsp;2%), and EBITDA margins of&nbsp;12.0%&nbsp;to&nbsp;12.1%&nbsp;(prior&nbsp;12.1%&nbsp;to&nbsp;12.3%). Updated adjusted EPS&nbsp;guidance&nbsp;excludes the&nbsp;$3.0 million&nbsp;tax benefit recorded in the fiscal 2024&nbsp;second quarter&nbsp;related to a deferred tax valuation allowance adjustment.&nbsp;Guidance&nbsp;incorporates current economic uncertainty and assumptions of easing end-market demand near term, as well as ongoing inflationary headwinds.&nbsp;Guidance&nbsp;does not assume contribution from Kopar (pending the transaction close) or future acquisitions.

Guidance

Applied Industrial Technologies Updates Fiscal 2024 Guidance, Now Expects Adj. EPS Of $9.55-$9.70 (Prior $9.35-$9.70) Vs. $9.66 Est, Sales Growth Of 1.5%-2.5% (Prior 1%-3%) Vs. $4.5B Est

The Federal Reserve&#8217;s recent decision to maintain high-interest rates for an extended period has sparked a debate over its potential impact on the U.S. economy. Despite the ongoing economic stability, the Fed&#8217;s stance has raised concerns among investors and the general public.
What Happened: Despite the current economic stability, the Federal Reserve has hinted at the possibility of maintaining high interest rates throughout 2024. This decision, driven by persistent inflation, has raised questions about its potential impact on the economy, <a href="https://www.cnbc.com/2024/04/24/why-the-fed-keeping-rates-higher-for-longer-may-not-be-such-a-bad-thing.html">reported</a> CNBC.
Recent remarks from Fed Chair Jerome Powell and other policymakers have solidified the belief that rate cuts are unlikely in the coming months. In fact, there has been discussion about the possibility of one or two additional hikes if inflation fails to further ease.
Quincy Krosby, Chief Global Strategist at LPL Financial, pointed out that the prolonged period of high rates could lead to an economic adjustment. The unexpected stance has left investors uncertain about the future, especially with the possibility of further rate hikes if inflation does not ease.
"If there's any sense that companies have to start cutting back costs and that leads to labor market trouble, this is the path of a potential problem with rates this high," Krosby said.
While the market has largely weathered the high-rate landscape, concerns remain about the potential impact on corporate profits and consumer behavior. The ongoing earnings season is expected to provide more clarity on these issues.
"I don't think that active monetary policy really moves the economy nearly as much as the Federal Reserve thinks it does," said David Kelly, chief global strategist at J.P. Morgan Asset Management.
See Also: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38358074/peter-schiff-warns-against-piling-risk-assets-like-tech-stocks-and-bitcoin-amid-inf?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Peter Schiff Warns Against Piling &#8216;Risk Assets&#8217; Like Tech Stocks And Bitcoin Amid Inflation Concerns: &#8216;In</a>
Despite the current economic stability, the Fed&#8217;s decision has raised concerns about its potential impact on the broader economy.
While the Fed&#8217;s decision to maintain high interest rates is a response to sustained inflation, it has raised concerns about its potential impact on the broader economy. The ongoing earnings season is expected to provide more clarity on the impact of high rates on corporate profits and consumer behavior, as per Krosby.
Why It Matters: The Fed&#8217;s decision to maintain high interest rates comes at a time when the U.S. economy is showing signs of robust growth. The <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/04/38405106/us-economy-expected-to-grow-2-5-in-q1-not-a-hard-landing-and-hardly-a-soft-one">U.S. economy is expected to grow by 2.5% in Q1</a>, following a 3.4% growth rate in the last quarter of 2023 and a 4.9% growth in the third quarter. This growth, however, has been accompanied by sustained inflation, which the Fed has been trying to manage through its monetary policy.
Former Dallas Fed President Robert Kaplan has criticized the <a href="https://www.benzinga.com/general/market-summary/24/04/38391252/were-buying-this-soft-landing-former-fed-governor-blames-government-spending-for-delaying-">current U.S. fiscal policies</a>, suggesting that they are hindering the Federal Reserve&#8217;s ability to lower interest rates amid ongoing economic pressures. Kaplan highlighted the contradiction between the Federal Reserve&#8217;s efforts to temper demand through tighter monetary policy and the government&#8217;s fiscal actions, which continue to stimulate demand.
Despite the recent inflation increases, Goldman Sachs economist Jessica Rindels has predicted a downturn in the core <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38389508/did-the-feds-strategy-pay-off-goldman-sachs-projects-steady-inflation-decline-in-20">Personal Consumption Expenditure</a> (PCE) Inflation, the Federal Reserve&#8217;s preferred inflation metric, for the remainder of the year. According to Rindels, the re-acceleration to a 4.0% average monthly annualized pace in early 2024 was influenced by transient factors that are expected to abate.
Read Next: <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38381361/us-private-sector-growth-unexpectedly-slows-in-april-marks-lowest-increase-in-4-mon?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Private Sector Growth Unexpectedly Slows In April, Marks Lowest Increase In 4 Months: &#8216;Drivers Of Inflation Have Changed&#8217;</a>
Federal Reserve Chair Jerome Powell. Photo courtesy of the Federal Reserve.
<div style="font-family: 'Lato', sans-serif">
<hr style="border: 0;height: 5px;background: #225aa9" />
<div style="background-color: #f5f5f5;background-position: center;background-size: cover;justify-content: center"></div>

 Engineered by 
 Benzinga Neuro, Edited by 
 
 <a href="None" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none"> 
 Kaustubh Bagalkote</a> 
 
 
<hr style="border: 0;height: 1px;background: #225aa9" />

 The GPT-4-based Benzinga Neuro content generation system exploits the 
 extensive Benzinga Ecosystem, including native data, APIs, and more to 
 create comprehensive and timely stories for you. 
 <a href="https://www.benzinga.com/topic/kaustubh-bagalkote" target="_blank" rel="noopener" style="color: #225aa9;text-decoration: none">Learn more.</a>
 
<hr style="border: 0;height: 5px;background: #225aa9" />
 </div>

Economics

Federal Reserve

Markets

Fed's High-Interest Rate Policy Spurs Debate Over Economic Impact: 'This Is The Path Of A Potential Problem...'

Baird analyst Catherine Schulte maintains Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) with a Outperform and lowers the price target from $621 to $620.

Baird Maintains Outperform on Thermo Fisher Scientific, Lowers Price Target to $620

WIIM

CARR

Carrier Global shares are trading lower following mixed Q1 financial results. The company also reduced its 2024 revenue guidance.

Baird analyst David Rescott maintains Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) with a Outperform and raises the price target from $79 to $84.

Baird Maintains Outperform on Boston Scientific, Raises Price Target to $84

MBLY

Mobileye Global Reiterated FY24 Revenue Outlook Of $1.830B-$1.960B Vs. $1.90B Estimate, Projects FY24 Adjusted Operating Income Of $270M-$360M

Caterpillar shares are trading lower after the company reported better-than-expected Q1 EPS but missed revenue estimates.

Needham analyst Mike Cikos reiterates ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Buy and maintains $900 price target.

Needham Reiterates Buy on ServiceNow, Maintains $900 Price Target

General

AULT

Ault Alliance's Subsidiary, Sentinum, Has Signed Its First Non-mining Colocation/Hosting Agreement Utilizing The Tier 3 Portion Of Its Approximately 100,000 Square Foot Enterprise-class Data Center

Baird analyst Jeff Johnson maintains Align Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALGN#NASDAQ">ALGN</a>) with a Outperform and raises the price target from $333 to $370.

ALGN

Baird Maintains Outperform on Align Tech, Raises Price Target to $370

MNST

Monster Beverage shares are trading lower after Truist Securities downgraded the stock from Buy to Sell and lowered its price target from $65 to $46.

NCLH

Shares of cruise stocks are trading higher in sympathy with Royal Caribbean, which raised its 2024 guidance.

Baird analyst Michael Bellisario maintains Hilton Worldwide Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLT#NYSE">HLT</a>) with a Outperform and raises the price target from $212 to $215.

Baird Maintains Outperform on Hilton Worldwide Holdings, Raises Price Target to $215

Merck shares are trading higher after the company reported better-than-expected Q1 financial results and raised its 2024 guidance.

<div>The Company does not anticipate receipt of any additional milestone payments from collaborations in the remainder of 2024.&nbsp;The Company anticipates operating expenses will decrease in 2024 relative to 2023.​&nbsp;With the availability of ZURZUVAE in the U.S. as an additional treatment for women with PPD, the Company anticipates ZULRESSO revenues will continue to decrease over time.</div>

SAGE

Sage Therapeutics Expects Cash & Equivalents Plus Funding To Support Its Operations Into 2026; Expects ZULRESSO Revenues To Continue To Decrease Over Time